Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Posts Tagged ‘antiviral’


Hepatitis C New Study On Drug Treatment In Vivo And In Vitro

By on Wednesday, February 20th, 2013 | No Comments

Hepatitis C virus (HCV) infection affects about 4.1 million in the United States and is the primary cause of liver cirrhosis and liver cancer. Current therapy against HCV is suboptimal. Daclatasvir, a direct acting antiviral (DAA) agent in development for the treatment of HCV, targets one of the HCV proteins (i.e…

Read More...

Antiviral therapy may halve risk of liver cancer after chronic hepatitis C infection, analysis indicates

By on Tuesday, October 23rd, 2012 | No Comments

Treating chronic hepatitis C infection with antiviral drugs could halve the risk of developing the most common form of liver cancer, in some cases, a new analysis indicates.

Read More...

Anti-HIV drug simulation offers ‘realistic’ tool to predict drug resistance and viral mutation

By on Monday, September 3rd, 2012 | No Comments

Pooling data from thousands of tests of the antiviral activity of more than 20 commonly used anti-HIV drugs, AIDS experts have developed what they say is the first accurate computer simulation to explain drug effects. Already, the model clarifies how and why some treatment regimens fail in some patients who lack evidence of drug resistance.

Read More...

Hepatitis C virus hijacks liver microRNA

By on Wednesday, January 4th, 2012 | No Comments

Scientists have now shown for the first time how a small RNA molecule that regulates gene expression in human liver cells has been hijacked by the hepatitis C virus to ensure its own survival — helping medical scientists understand why a new antiviral drug appears to be effective against the virus.

Read More...

Scientists identify point of entry for deadly Ebola virus

By on Thursday, August 25th, 2011 | No Comments

Using an unusual human cell line, researchers have performed a genetic screen and identified a protein used by the Ebola virus to gain entry into cells and begin replicating. The discovery may offer a new approach for the development of antiviral therapeutics. Ebola virus, the cause of Ebola hemorrhagic fever, is one of the deadliest known viruses affecting humans.

Read More...

New compounds show promise against hepatitis C infection

By on Wednesday, April 13th, 2011 | No Comments

Two bioflavonoids, catechin and naringenin, have displayed antiviral activity on tissue culture infected with Hepatitis C.

Read More...